Ph.D., President & CEO, Epic Sciences
Dr. Prahalad is President and CEO of Epic Sciences, Inc. (EPIC), a venture backed company that builds predictive tests of drug response that extend life for late stage cancer patients. Prior to joining EPIC, Dr. Prahalad held various roles at Life Technologies Corporation, a global leader in reagents and instruments for biomedical research. His final role at Life Technologies was VP, Corporate Strategy. Prior to joining Life Technologies, Dr. Prahalad was VP of Business Development for Sequenom, Inc. Dr. Prahalad received his B.Sc. with Honors from the University of Michigan and Doctorate in Biochemistry & Molecular Pharmacology from Harvard University.
Presentation Title and Company Description
Liquid Biopsy Showcase: Extending Life with Predictive and Proven Tests
Epic Sciences develops tests to extend the lives of late stage cancer patients. We enable the rapid, non-invasive detection of molecular & cellular changes in cancer over time and predict which patients will live longer on standard of care drugs.